# NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

> **NCT03771404** · NA · UNKNOWN · sponsor: **Hellenic Oncology Research Group** · enrollment: 50 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT03771404
- **Lead sponsor:** Hellenic Oncology Research Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-05
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03771404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03771404, "NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03771404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*